Explained herein are pharmaceutical packaging methods which avoid oxidative degradation of morphine, hydromorphone, promethazine and other oxygen-delicate prescription drugs, these units which include a syringe by having an oxygen permeable idea cap, a hermetically sealed oxygen barrier blister packaging with quite minimal permeability to oxygen an